Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pharmacology & Therapeutics
|
December 1, 1991
Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression?
C A Stein, J L Tonkinson, L Yakubov
Antisense Research and Development
|
January 1, 1993
Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of human immunodeficiency virus type 1 gp120
C A Stein, A M Cleary, L Yakubov, et al.
Nucleic Acids Symposium Series
|
January 1, 1991
Mode of uptake of 5'-cholesteryl-linked phosphodiester oligodeoxynucleotides in HL60 cells
C A Stein, L Yakubov, L M Zhang, et al.
The Journal of Biological Chemistry
|
September 5, 1993
Oligodeoxynucleotides interact with recombinant CD4 at multiple sites
L Yakubov, Z Khaled, L M Zhang, et al.
Nucleic Acids Symposium Series
|
January 1, 1991
Interaction of oligonucleotides with cellular receptors
L Yakubov, L Yurchenko, M Nechaeva, et al.
Biochemistry
|
May 11, 1993
Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells
C A Stein, J L Tonkinson, L M Zhang, et al.
Antisense & Nucleic Acid Drug Development
|
January 1, 1996
Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augment binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independency of G-tetrad formation
S Lederman, G Sullivan, L Benimetskaya, et al.
Antisense Research and Development
|
January 1, 1994
Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study
J L Tonkinson, M Guvakova, Z Khaled, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1993
Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy
A M Krieg, J Tonkinson, S Matson, et al.
Journal of the American College of Cardiology
|
October 3, 2003
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)
Albert W Chan, David J Moliterno, Peter B Berger, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pharmacology & Therapeutics
|
December 1, 1991
Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression?
C A Stein, J L Tonkinson, L Yakubov
Antisense Research and Development
|
January 1, 1993
Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of human immunodeficiency virus type 1 gp120
C A Stein, A M Cleary, L Yakubov, et al.
Nucleic Acids Symposium Series
|
January 1, 1991
Mode of uptake of 5'-cholesteryl-linked phosphodiester oligodeoxynucleotides in HL60 cells
C A Stein, L Yakubov, L M Zhang, et al.
The Journal of Biological Chemistry
|
September 5, 1993
Oligodeoxynucleotides interact with recombinant CD4 at multiple sites
L Yakubov, Z Khaled, L M Zhang, et al.
Nucleic Acids Symposium Series
|
January 1, 1991
Interaction of oligonucleotides with cellular receptors
L Yakubov, L Yurchenko, M Nechaeva, et al.
Biochemistry
|
May 11, 1993
Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells
C A Stein, J L Tonkinson, L M Zhang, et al.
Antisense & Nucleic Acid Drug Development
|
January 1, 1996
Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augment binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independency of G-tetrad formation
S Lederman, G Sullivan, L Benimetskaya, et al.
Antisense Research and Development
|
January 1, 1994
Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study
J L Tonkinson, M Guvakova, Z Khaled, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1993
Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy
A M Krieg, J Tonkinson, S Matson, et al.
Journal of the American College of Cardiology
|
October 3, 2003
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)
Albert W Chan, David J Moliterno, Peter B Berger, et al.
Page
of 1